This Week in Startups cover image

This Week in Startups

E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries

Nov 6, 2019
Sajith Wickramasekara, CEO and co-founder of Benchling, revolutionizes scientific efficiency with a cloud-based platform. He shares his journey into life sciences and discusses the promise of immunotherapy and breakthroughs in gene therapy. The ethics of editing human embryos sparks a heated debate, distinguishing legitimate advancements from quackery. Insights into genetically modified crops and their implications for health provide a well-rounded view of the future in biotechnology. It's a thought-provoking conversation about the intersection of science, morality, and innovation.
54:30

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner